Product Information

AMLODIPINE-OLMESARTAN 5-40 MG is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.3525 per EA under NDC 69238267601. Its NADAC has been published 121 times since Jul 31, 2024.

FDA first approved this application on Dec 3, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-OLMESARTAN 5-40 MG

Amlodipine and Olmesartan Medoxomil
$0.3525per EA

Strength

5; 40 mg/1; mg/1

NDC

69238267601

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209010

FDA Approved

12/3/2018

TE Code

AB

On Market Since

12/3/2018

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has been published 121 times since Jul 31, 2024, and over the history we have for it it has risen 11.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3525 per EA
All-time high$0.4599 (Oct 16, 2024)
All-time low$0.2762 (Apr 22, 2026)
52-week high$0.3525
52-week low$0.2762
Median price$0.3362
Average price$0.3502
Largest weekly change+33.8% (Aug 21, 2024)
Weeks tracked121
Tracking sinceJul 31, 2024

Price History

1W

+4.9%

1M

+10.6%

3M

+12.9%

6M

+23.7%

1Y

+5.5%

3Y

N/A

5Y

N/A

All

+11.1%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 5-40 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-40 MG, manufactured by Amneal Pharmaceuticals NY LLC, is $0.3525 per EA (NDC 69238267601), effective Nov 18, 2026.

How has the price of AMLODIPINE-OLMESARTAN 5-40 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has risen 11.1%. It has been tracked across 121 weekly CMS publications since Jul 31, 2024.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-40 MG?

Since Jul 31, 2024, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has ranged from a low of $0.2762 (Apr 22, 2026) to a high of $0.4599 (Oct 16, 2024), with a median of $0.3362 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-40 MG?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE-OLMESARTAN 5-40 MG, is $0.2788 per EA — about 21% below AMLODIPINE-OLMESARTAN 5-40 MG.

Who manufactures AMLODIPINE-OLMESARTAN 5-40 MG?

AMLODIPINE-OLMESARTAN 5-40 MG (NDC 69238267601) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.